Yale study shows immunotherapy drug helps patients with metastatic melanoma
New research suggests that melanoma patients with brain metastases should be given a combination of two types of checkpoint inhibitors.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news
More News: Brain | Immunotherapy | Melanoma | Neurology | Science | Skin Cancer | Study | Universities & Medical Training | Yale